(S)-N-(1-(3-Methylbutanamido)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide
| Product Name |
(S)-N-(1-(3-Methylbutanamido)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide
|
| Product Code |
DA-B169-25
|
| Chemical name |
(S)-N-(1-(3-Methylbutanamido)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide
|
| Synonyms |
(2S)-N-(3-Methylbutanoyl)-3-phenyl-2-(pyrazin-2- ylformamido)propanamide;
|
| Impurity |
NA
|
| CAS Number |
862894-96-0
|
| Alternate CAS # |
NA
|
| Molecular form |
C19H22N4O3
|
| Appearance |
White Solid
|
| Melting Point |
NA
|
| Mol. Weight |
354.41
|
| Storage |
2-8°C Hygroscopic, Refrigerator, Under Inert Atmosphere
|
| Solubility |
NA
|
| Stability |
NA
|
| Category |
impurities,metabolites,pharmaceutical standards,intermediates,fine chemicals
|
| Boiling Point |
NA
|
| Applications |
N(1-(3-Methylbutanamido) N(1-Des(boric Acid)) Bortezomib is an impurity of Bortezomib, the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer.
|
| Dangerous Goods Info |
NA
|
| References |
NA
|
| Extra Notes |
NA
|
| Documents (MSDS) |
No Data Available
|
| Keywords |
NA |
